ActiMed Laboratories, Inc.
15Patents
0Active
15Granted
34Portfolio score
Filing activity: May 17, 1989 → Apr 17, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5540709A | Lancet device | Human Necessities | 339 | Expired |
| US5234813A | Method and device for metering of fluid samples and detection of analytes therein | Emerging Cross-Sectional Technologies | 160 | Expired |
| US5087556A | Method for quantitative analysis of body fluid constituents | Emerging Cross-Sectional Technologies | 102 | Expired |
| US5411858A | Manufacturing process for sample initiated assay device | Emerging Cross-Sectional Technologies | 60 | Expired |
| US5766552A | Apparatus for red blood cell separation | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5447689A | Method and apparatus for flow control | Physics | 32 | Expired |
| US5652148A | Method and apparatus for red blood cell separation | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5286626A | Process and apparatus for direct determination of low density lipoprotein | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5660798A | Apparatus for red blood cell separation | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5411870A | Process and apparatus for direct determination of low density lipoprotein | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5518891A | Dye forming composition and detection of hydrogen peroxide therewith | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5914271A | Fertility test | Human Necessities | 8 | Expired |
| US5610025A | Inhibition of interfering endogenous enzyme activity in assays of biological fluids | Chemistry; Metallurgy | 7 | Expired |
| US5710012A | Salt of 6-carboxy-3-methylbenzothiazolone hydrazone hydrate in colorimetric determination of hydrogen peroxide | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5556743A | Method for immobilizing dye on substrates | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.